Tomas Orozco - 02 May 2024 Form 4 Insider Report for NeueHealth, Inc. (NEUE)

Signature
/s/ Eric Halverson for Tomas Orozco, Attorney-in-Fact
Issuer symbol
NEUE
Transactions as of
02 May 2024
Net transactions value
$0
Form type
4
Filing time
06 May 2024, 18:13:19 UTC
Previous filing
20 Mar 2024
Next filing
07 Jan 2025

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NEUE Restricted Stock Units Award $0 +72,000 $0.000000 72,000 02 May 2024 Common Stock 72,000 Direct F1, F2, F3
transaction NEUE Restricted Stock Units Award $0 +180,000 $0.000000 180,000 02 May 2024 Common Stock 180,000 Direct F1, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F2 This grant was approved on March 11, 2024 by the Issuer's Compensation and Human Capital Committee as part of the Issuer's annual equity grants, subject to shareholder approval of an amendment to the Issuer's Amended and Restated 2021 Omnibus Incentive Plan, which approval was obtained on May 2, 2024.
F3 These restricted stock units vest in three equal annual installments beginning on March 11, 2025.
F4 This grant was approved on October 11, 2023 by the Issuer's Compensation and Human Capital Committee, subject to shareholder approval of an amendment to the Issuer's Amended and Restated 2021 Omnibus Incentive Plan, which approval was obtained on May 2, 2024.
F5 100% of these restricted stock units vest on October 11, 2026.